Café

© 2026 Longbridge｜Terms of Service Privacy Policy

AKESO

09926

98.7508.76% ( +7.950 )

Delay Trading: Sep 4, 11:35:59

OverviewOverview NewsNews PostsPosts FinancialsFinancials ForecastForecast ValuationValuation ShareholdersShareholders ProfileProfile

LongbridgeAI

Daiwa Slightly Raises Confidence in Success of Global First-line NSCLC Phase III Trial OS After AKESO HARMONi-2 Interim OS Analysis Meets Target
AASTOCKS News·21 minutes ago
09926+8.87%
CICC Cuts AKESO TP to HKD120, Focuses on Harmoni-2 and Harmoni-3 Data
AASTOCKS News·6 minutes ago
09926+8.87%
Akeso surges 10% as HARMONi-2 trial meets survival endpoint
HK Stock Market Update·24 minutes ago
09926+8.87%
STOCKS | Kuaishou, Xiaomi, JD.com And Akeso Rise In Hong Kong Trading
CoinLive·2 hours ago
JD-0.32%KJD-0.96%
Akeso surged 9% on positive Phase III lung cancer data from partner
HK Stock Market Update·2 hours ago
09926+8.87%
Summit Therapeutics Stock (SMMT) Rallies on Positive Clinical Trial Results
Tip Ranks·12 hours ago
SMMT+17.33%09926+8.87%
Summit Therapeutics strengthened by positive ivonescimab survival results
Tip Ranks·14 hours ago
SMMT+17.33%09926+8.87%
Akeso, Inc. (9926) Gets a Buy from UBS
Tip Ranks·14 hours ago
09926+8.87%
Akeso edges up after ivonescimab meets OS endpoint in Phase III trial
HK Stock Market Update·1 day ago, 01:38 AM
09926+8.87%
Akeso says ivonescimab meets overall survival endpoint in Phase III HARMONi-2 lung cancer trial
PUBT·1 day ago, 09:01 PM
09926+8.87%
Ivonescimab Monotherapy Demonstrates Statistically Significant Overall Survival Benefit Compared to Pembrolizumab Monotherapy in PD-L1-Positive Advanced NSCLC in HARMONi-2 Study Conducted by Akeso in China | SMMT Stock News
StockTitan·1 day ago, 01:41 PM
SMMT+17.33%09926+8.87%
Unbundling and Restructuring: Value Chain Evolution Across Distinct Sectors
Global Report·2 days ago, 09:18 AM
02419+4.05%81211+0.96%
CMBI Cuts AKESO TP to HKD138.42; Ivonescimab Data Readout in 2H Seen as Catalyst
AASTOCKS News·2 days ago, 04:21 AM
09926+8.87%
JPM Cuts AKESO TP to HKD125, Interim Revenue Far Misses Expectations
AASTOCKS News·2 days ago, 04:15 AM
09926+8.87%
D Bkg Cuts AKESO TP to HKD127 as Interim Results Miss Expectations
AASTOCKS News·Aug 31 at 08:31 AM
09926+8.87%